SFX by Ex Libris Inc.

Title:	4,1-Benzoxazepinone analogues of efavirenz (Sustiva™) as HIV-1 reverse transcriptase inhibitors
Source:	Bioorganic & Medicinal Chemistry Letters [0960-894X] Cocuzza, Anthony yr:2001

Basic

Full text

Full text available via EZB-NALI5-00465 Elsevier Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Cocuzza, A J J. "Synthesis and evaluation of efavirenz (Sustiva) analogues as HIV-1 reverse transcriptase inhibitors: replacement of the cyclopropylacetylene side chain." Bioorganic & medicinal chemistry letters 11.9 (2001): 1177-9.
description	2.	Kaye, P. "Benzodiazepine analogs. Part 9. Kinetics and mechanism of the azidotrimethylsilane-mediated Schmidt reaction of flavanones." Journal of the Chemical Society. Perkin transactions. II 4 (1995): 835-.
description	3.	"T Cell Depletion During All Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract." Pediatrics / 116.2: -573.
description	4.	Dallavalle, S. "Novel 7-substituted camptothecins with potent antitumor activity." Journal of medicinal chemistry 43.21 (2000): 3963-3969.
description	5.	Yadav, J. "Azido-Schmidt reaction for the formation of amides, imides and lactams from ketones in the presence of FeCl3." Tetrahedron Letters 49.32 (2008): 4742-4745.
description	6.	Schmidt, Shaun E. "Efficient syntheses of cyclopropylacetylene, a crucial synthetic intermediate for Efavirenz (DMP-266)." Synlett 1999.12 (1999): 1948-1950.
description	7.	RICKARD, David J. "Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells." Bone 39.6 (2006): 1361-72.
description	8.	Mphahlele, M. "Benzodiazepine analogs. Part 18. 13C NMR analysis of Schmidt rearrangement products from flavanone analogs." Magnetic resonance in chemistry 36.1 (1998): 69-.
description	9.	Kaye, Perry T. "Benzodiazepine analogs. Part 14. Synthesis of 2-phenyl-1,4-benzoxazepin-5(4H)-one." Synthetic communications 26.20 (1996): 3677-.
description	10.	"T Cell Depletion during all Stages of HIV Disease Occurs Predominantly in the Gastrointestinal Tract." The journal of experimental medicine. 200.6: 749-759.
description	11.	Hyz, K. "Topotecan dynamics, tautomerism and reactivity - (1)H/(13)C NMR and ESI MS study." Magnetic resonance in chemistry 48.8 (2010): 575-584.
description	12.	Adkins, J C C. "Efavirenz." Drugs 56.6 (1998): 1055-6.
description	13.	Kingsbury, William D. "Synthesis of water-soluble (aminoalkyl)camptothecin analogs: inhibition of topoisomerase I and antitumor activity." Journal of medicinal chemistry 34.1 (1991): 98-107.
description	14.	McDonald, Iain M. "Discovery and Characterization of Novel, Potent, Non-Peptide Parathyroid Hormone-1 Receptor Antagonists." Journal of medicinal chemistry 50.20 (2007): 4789-4792.
description	15.	Martin, T J J. "Mechanisms involved in skeletal anabolic therapies." Annals of the New York Academy of Sciences 1068.1 (2006): 458-470.
description	16.	Sharghi, H. "Solvent-free and one-step Beckmann rearrangement of ketones and aldehydes by zinc oxide." Synthesis 2002.8 (2002): 1057-1060.
description	17.	Tietze, Lutz F. "Stereoselective synthesis of novel 19-nor-steroids by a double Heck reaction." European journal of organic chemistry 2011.9 (2001): 1619-106.
description	18.	Carter, Percy H. "Discovery of a small molecule antagonist of the parathyroid hormone receptor by using an N-terminal parathyroid hormone peptide probe." Proceedings of the National Academy of Sciences of the United States of America 104.16 (2007): 6846-51.
description	19.	Gimble, J M M. "Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?" Bone 27.2 (2000): 177-84.
description	20.	Ruester, B. "Mesenchymal stem cells display coordinated rolling and adhesion behavior on endothelial cells." Blood 108.12 (2006): 3938-3944.